Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Open Angle Glaucoma or Ocular Hypertension”

145 trials

Showing 20 of 145 results

Not applicableStudy completedNCT02544646
What this trial is testing

Changes in Ocular Rigidity After Trabeculectomy in Patients With POAG

Who this might be right for
GlaucomaPrimary Open Angle GlaucomaPseudoexfoliation Glaucoma
Medical University of Vienna 53
Testing effectiveness (Phase 2)Study completedNCT03858894
What this trial is testing

Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Once Daily and Twice Daily in Subjects With Primary Open-Angle Glaucoma SPECTRUM 6

Who this might be right for
Primary Open-angle Glaucoma and Ocular Hypertension
Santen Inc. 98
Post-approval studies (Phase 4)Study completedNCT00759239
What this trial is testing

Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-angle GlaucomaOcular Hypertension
Alcon Research 36
Not applicableStudy completedNCT01646151
What this trial is testing

A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Allergan 2,580
Large-scale testing (Phase 3)Not Yet RecruitingNCT07617532
What this trial is testing

Efficacy and Safety of DNN.31.19.026 for Ocular Hypertension or Primary Open-Angle Glaucoma

Who this might be right for
Ocular HypertensionPrimary Open Angle Glaucoma
Ache Laboratorios Farmaceuticos S.A. 336
Not applicableStudy completedNCT03889652
What this trial is testing

Optical Coherence Tomography of Nerve Fiber Layer and Ganglion Cell Complex After Cataract Extraction

Who this might be right for
CataractPrimary Open-angle Glaucoma
Kasr El Aini Hospital 48
Not applicableLooking for participantsNCT07310719
What this trial is testing

A Comparative Study of Intraocular Pressure Control Using Selective Laser Trabeculoplasty and Latanoprost as Initial Treatments for Primary Open Angle Glaucoma and Ocular Hypertension in Lagos State University Teaching Hospital

Who this might be right for
Primary Open Angle Glaucoma or Ocular Hypertension
Lagos State Health Service Commission 138
Not applicableStudy completedNCT00801437
What this trial is testing

Non Interventional Study With Primary Open Angle Glaucoma and/or Ocular Hypertension Patients Treated With Xalacom® After Failure of Previous Antiglaucoma Therapy.

Who this might be right for
Glaucoma, Open-angle
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 457
Not applicableStudy completedNCT01628588
What this trial is testing

Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Allergan 854
Testing effectiveness (Phase 2)Looking for participantsNCT06964191
What this trial is testing

Evaluate Efficacy and Safety of PA5108 Ocular Implants in Primary Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
PolyActiva Pty Ltd 75
Not applicableWithdrawnNCT04064918
What this trial is testing

Effects of Netarsudil and Timolol on Retinal Blood Vessel Density and Visual Acuity

Who this might be right for
OAG - Open-Angle GlaucomaOHT - Ocular Hypertension
University of California, San Diego
Not applicableStudy completedNCT01853085
What this trial is testing

Patients With Primary Open Angle Glaucoma or Ocular Hypertension Switched to Lumigan® UD Monotherapy for Medical Reasons

Who this might be right for
Glaucoma, Primary Open AngleOcular Hypertension
Allergan 1,830
Large-scale testing (Phase 3)Study completedNCT05495061
What this trial is testing

A Comparative Confirmatory Study of STN1012600 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open Angle Glaucoma, Ocular Hypertension
Santen Pharmaceutical Co., Ltd. 325
Post-approval studies (Phase 4)Study completedNCT01336569
What this trial is testing

Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol

Who this might be right for
Glaucoma
Alcon Research 50
Post-approval studies (Phase 4)Study completedNCT00300079
What this trial is testing

Study of the Intraocular Pressure (IOP)-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% in Patients With Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open Angle GlaucomaOcular Hypertension
Alcon Research 30
Early research (Phase 1)Study completedNCT03293992
What this trial is testing

The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
Glaucoma, Open-angleOcular Hypertension
Hoffmann-La Roche 27
Large-scale testing (Phase 3)Study completedNCT01217606
What this trial is testing

Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Allergan 185
Testing effectiveness (Phase 2)Study completedNCT01693315
What this trial is testing

Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma

Who this might be right for
GlaucomaOcular HypertensionEye Disease
Amakem, NV 82
Not applicableStudy completedNCT01628614
What this trial is testing

Intraocular Pressure (IOP) Reduction in Newly Diagnosed Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Allergan 4,812
Large-scale testing (Phase 3)Ended earlyNCT02801617
What this trial is testing

Non-inferiority of PRO-067 Ophthalmic Solution vs GAAP Ofteno® in Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open Angle GlaucomaOcular Hypertension
Laboratorios Sophia S.A de C.V. 116
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation